| 1 |
[GO] |
2025―Nov―20 |
A cross-sectional study of the risk of cognitive impairment in the context of COVID-19 and a prognostic scale for the selection of psychopharmacotherapy for outpatients. |
Mikhail Yu. Sorokin, Ekaterina S. Gerasimchuk, Nataliya B. Lutova, Elena Y Zubova |
| 2 |
[GO] |
2023―Jul―24 |
Prospects for the use of bovhyaluronidase azoxymer in the post-COVID period after a severe COVID-19: A clinical case |
Tatiana A. Sergeeva, Dmitriy A. Kachanov, Evgeniya A. Belogurova, Anfisa B. Batalova, Andrei V. Pavlysh |